Solara Active Pharma Sciences Ltd Quarterly Results, Profit & Loss, Balance Sheet (SOLARA) | Stocksigma

Solara Active Pharma Sciences Ltd (SOLARA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Solara Active Pharma Sciences Ltd reported sales of ₹417 Cr, operating profit of ₹77 Cr (OPM 18%) and net profit of ₹28 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

SOLARA quarterly results (₹ Cr)
Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	300	273	319	314	349	387	382	417
Expenses	243	228	262	279	312	330	320	340
Operating Profit	58	45	57	35	37	58	62	77
OPM	19%	17%	18%	11%	11%	15%	16%	18%
Other Income	1	6	1	0	-7	6	3	-4
Interest	27	29	24	21	22	28	22	18
Depreciation	25	24	24	24	26	26	27	27
Profit before tax	8	-2	11	-10	-17	10	16	28
Tax	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	8	-2	11	-10	-17	10	16	28
EPS in Rs	2.24	-0.58	2.91	-2.79	-4.82	2.65	3.38	5.86

SOLARA profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,268	1,444	1,289	1,284	1,369	1,535
Expenses	1,188	1,309	1,384	1,077	1,182	1,301
Operating Profit	81	134	-95	206	187	234
OPM	6%	9%	-7%	16%	14%	15%
Other Income	16	22	-185	8	0	-2
Interest	75	90	105	115	95	89
Depreciation	112	111	103	99	100	105
Profit before tax	-91	-45	-488	1	-7	37
Tax	-36%	-50%	16%	0%	0%	-
Net Profit	-58	-22	-567	1	-7	37
EPS in Rs	-12.11	-4.62	-118.21	0.15	-2.05	7.07
Dividend Payout	0%	-49%	0%	0%	0%	-

SOLARA balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026
Equity Capital	36	40	44	45	48
Reserves	898	1,054	1,210	1,208	1,388
Borrowings	1,012	796	646	687	591
Other Liabilities	406	342	393	393	427
Total Liabilities	2,351	2,232	2,293	2,333	2,454
Fixed Assets	1,268	1,193	1,232	1,238	1,201
CWIP	256	280	230	205	208
Investments	2	2	2	5	3
Other Assets	825	757	829	886	1,043
Total Assets	2,351	2,232	2,293	2,333	2,454

SOLARA cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-242	156	109	213	153
Cash from Investing Activity	-243	-81	-4	-37	-99
Cash from Financing Activity	334	-113	-106	-180	-54
Net Cash Flow	-151	-38	0	-4	1
Free Cash Flow	-451	46	69	173	101
CFO/OP	-277%	106%	-113%	104%	83%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	-277	106	-113	104	83

SOLARA ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	141	136	99	93	117
Inventory Days	321	258	163	185	170
Days Payable	154	142	142	144	146
Cash Conversion Cycle	308	252	120	134	140
Working Capital Days	37	20	-128	-62	-24
ROCE	0%	2%	-9%	6%	5%